Ropivacaine Hydrochloride Injection, Solution
NDC Package 0143-9195-24
Package Information
Ropivacaine Hydrochloride injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management.Surgical Anesthesia: epidural block for surgery including cesarean section; major nerve block; local infiltrationAcute Pain Management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration. This formulation utilizes a injection, solution delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0143-9195 and is authorized under FDA application ANDA211907.
Identification & Billing
- RxCUI: 1734347 - ROPivacaine HCl 0.2 % in 100 ML Injection
- RxCUI: 1734347 - 100 ML ropivacaine hydrochloride 2 MG/ML Injection
- RxCUI: 1734347 - ropivacaine HCl 0.2 % per 100 ML Injection
- RxCUI: 1734347 - ropivacaine HCl 200 MG per 100 ML Injection
- RxCUI: 1734355 - ROPivacaine HCl 0.2 % in 200 ML Injection
Clinical Specifications
- Epidural - Administration upon or over the dura mater.
- Infiltration - Administration that results in substances passing into tissue spaces or into cells.
- Perineural - Administration surrounding a nerve or nerves.
Regulatory & Marketing
Hierarchy Structure
- 0143 - Hikma Pharmaceuticals Usa Inc.
- 0143-9195 - Ropivacaine Hydrochloride
- 0143-9195-24 - 24 BAG in 1 CASE / 100 mL in 1 BAG (0143-9195-01)
- 0143-9195 - Ropivacaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0143-9195-24 identifies a specific commercial package of 24 bag in 1 case / 100 ml in 1 bag (0143-9195-01) of Ropivacaine Hydrochloride, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This injection, solution is formulated for epidural; infiltration; perineural use and contains ropivacaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on November 07, 2025. The current certification is valid through December 31, 2027.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00143919524. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
